Trabikibart (CSL311), a betac (CSF2RB)-specific, fully human monoclonal antibody, binds to a unique epitope that is specific to the cytokine-binding site of the human betac receptor. Trabikibart has picomolar binding affinity for the human betac receptor. Trabikibart is a potent inhibitor of the combined effects of IL-3, GM-CSF and IL-5 on the survival of eosinophils. Trabikibart has the potential for chronic inflammatory diseases research[1].
Molecular Weight:
(144.66 kDa)
Purity:
99.17
CAS Number:
[2643974-98-3]
Target:
c-Fms
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
